My watch list  

7 Current news about the topic celecoxib


You can refine your search further. Select from the filter options on the left to narrow down your results.

Scientists show commonly prescribed painkiller slows cancer growth


Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that one of the most widely prescribed pain and anti-inflammation drugs slows the growth rate of a specific kind of cancer in animal models and suggests the medication could have the same effect on other types ...


Association between certain pain relievers and heart attack


For women taking certain kinds of pain relievers, a heart attack could be waiting in their medicine cabinets. A University of Florida study has found that the regular use of some non-steroidal anti-inflammatory drugs, or NSAIDs, increases the risk of stroke, heart attack and death in ...


Early detection of cancer


Molecules that bind and illuminate proteins specific to tumor cells are key to detecting cancer as early as possible. The cyclooxygenase-2 (COX-2) enzyme is just such a protein, as the concentration of COX-2 is greater in cancer cells than in adjacent normal tissues. Therefore, attaching a ...


UF study strengthens concerns about long-term use of certain painkillers


Painkillers such as ibuprofen, naxopren and celecoxib provide needed relief for many patients who have chronic pain. But an ongoing source of contention is whether those drugs and others in their class known as nonsteroidal anti-inflammatory drugs, or NSAIDs, are linked to harmful health ...


Creabilis Appoints Dr. Eliot Forster as its New Chief Executive Officer


Creabilis SA announced the appointment of Eliot Forster as its new Chief Executive Officer. Dr Forster brings to Creabilis significant drug development experience having brought a number of molecules to market. Dr Forster has close to 20 years industry experience in biotechnology and ...


Generex Oncology Names Dr. Craig Eagle to its Scientific Advisory Board to Assist with its Proprietary Cancer Vaccines Program


Generex Biotechnology Corporation announced that it has named Craig Eagle, M.D. to its scientific advisory board. Dr. Eagle brings a wealth of oncology experience to help the Company’s wholly-owned subsidiary, Antigen Express, Inc., dba “Generex Oncology”, further its synthetic cancer and ...


Common anti-inflammatory drug could help prevent skin cancers, Stanford researcher says


A widely-available anti-inflammatory prescription drug can reduce the risk of a common skin cancer in humans, according to a researcher at Stanford's School of Medicine. Although oral administration of the drug, celecoxib, is associated with an increased risk of heart attack and stroke in some ...


Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE